Europe Travel Vaccines Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Europe Travel Vaccines Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Europe Travel Vaccines Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Europe Travel Vaccines Market Regional Analysis

6.2 Europe Travel Vaccines Market Revenue 2019-2028 (US$ Million)

6.3 Europe Travel Vaccines Market Forecast Analysis

7. Europe Travel Vaccines Market Analysis – by Product

7.1 Hepatitis A

7.1.1 Overview
7.1.2 Hepatitis A: Europe Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.2 Hepatitis B

7.2.1 Overview
7.2.2 Hepatitis B: Europe Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)

7.3 Meningococcal Vaccines

7.3.1 Overview
7.3.2 Meningococcal Vaccines: Europe Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)

8. Europe Travel Vaccines Market Analysis – by Application

8.1 Domestic Travel and Outbound Travel

8.1.1 Overview
8.1.2 Domestic Travel and Outbound Travel : Europe Travel Vaccines Market – Revenue and Forecast, 2019-2028 (US$ Million)

9. Europe Travel Vaccines Market – Europe Analysis

9.1 Overview

9.2 Europe

9.2.1 Europe Travel Vaccines Market Breakdown, by Key Country, 2022 and 2028 (%)
9.2.1.1 Europe Travel Vaccines Market – Revenue and Forecast Analysis – by Country
9.2.1.1 UK: Europe Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.1.1 UK: Europe Travel Vaccines Market Breakdown, by Product
9.2.1.1.2 UK: Europe Travel Vaccines Market Breakdown, by Application

9.2.1.2 Germany: Europe Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.2.1 Germany: Europe Travel Vaccines Market Breakdown, by Product
9.2.1.2.2 Germany: Europe Travel Vaccines Market Breakdown, by Application

9.2.1.3 France: Europe Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.3.1 France: Europe Travel Vaccines Market Breakdown, by Product
9.2.1.3.2 France: Europe Travel Vaccines Market Breakdown, by Application

9.2.1.4 Russia: Europe Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.4.1 Russia: Europe Travel Vaccines Market Breakdown, by Product
9.2.1.4.2 Russia: Europe Travel Vaccines Market Breakdown, by Application

9.2.1.5 Italy: Europe Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.5.1 Italy: Europe Travel Vaccines Market Breakdown, by Product
9.2.1.5.2 Italy: Europe Travel Vaccines Market Breakdown, by Application

9.2.1.6 Rest of Europe: Europe Travel Vaccines Market – Revenue and Forecast to 2028 (US$ Million)

9.2.1.6.1 Rest of Europe: Europe Travel Vaccines Market Breakdown, by Product
9.2.1.6.2 Rest of Europe: Europe Travel Vaccines Market Breakdown, by Application

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Industry Landscape

11.1 Overview

11.2 Market Initiative

11.3 Partnerships and Collaborations

11.4 Other Developments

12. Company Profiles

12.1 Abbott

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 Dynavax Technologies

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Emergent BioSolutions Inc.

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 GlaxoSmithKline plc

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Merck & Co., Inc.

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

12.6 Novartis AG

12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments

12.7 Pfizer Inc.

12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments

12.8 Sanofi

12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments

12.9 Valneva SE.

12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments

13. Appendix

13.1 About Business Market Insights

13.2 List of Abbreviations

Europe Travel Vaccines Market